Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks

por Lebozec, Kristell, Jandrot-Perrus, Martine, Avenard, Gilles, Favre-Bulle, Olivier, Billiald, Philippe
Publicado 2017

Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet Aggregation

por Renaud, Lionel, Lebozec, Kristell, Voors‐Pette, Christine, Dogterom, Peter, Billiald, Philippe, Jandrot Perrus, Martine, Pletan, Yannick, Machacek, Matthias
Publicado 2020

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition

por Billiald, Philippe, Slater, Alexandre, Welin, Martin, Clark, Joanne C., Loyau, Stéphane, Pugnière, Martine, Jiacomini, Isabella G., Rose, Nadia, Lebozec, Kristell, Toledano, Elie, François, Déborah, Watson, Steve P., Jandrot-Perrus, Martine
Publicado 2022